A normal range is where 95% of a broad population lands. An optimal range is a narrower target someone proposes for feeling or ageing well. Normal is a lab statistic; optimal is an opinion, and only a few optimal targets have guideline backing.
A "normal" reference range is statistical — labs set it so roughly 95% of a broad, unselected population falls inside it, whether or not those people are actually healthy. An "optimal" range is a narrower band proposed mostly by functional-medicine sources, meant to reflect fewer symptoms or better long-term markers. Optimal ranges aren't standardised: they vary from source to source, and only some are backed by mainstream clinical evidence.
| Range | Who sets it | What it answers | Evidence behind the number |
|---|---|---|---|
| Normal (reference range) | Your lab, from a population sample | Is this result unusual? | Statistical: the middle 95% of the people tested |
| Guideline target | Bodies such as ADA, ACC/AHA | Does this result raise disease risk? | Outcome studies. Some markers have a named borderline band (prediabetes, "borderline high" LDL) |
| Optimal (functional) | Functional-medicine sources | Is this where people feel best? | Practice patterns; varies by source |
| Longevity target | Named physicians and researchers (Attia, Patrick, Means…) | Is this where people age best? | Their reading of the research; attributed, not standardised |
The specific "optimal" figures below are attributed to their original sources so you can see whose opinion they represent — they are not FixFirst's clinical claims.
Reference ranges are built from a population, not from an outcome.
When a lab sets a reference range, it typically draws blood from a large sample of people, throws out the top and bottom 2.5%, and calls the remaining 95% "normal." That sample usually isn't screened for how healthy those people actually are — it includes people who are sedentary, under-slept, or metabolically stressed alongside people in excellent health. The range describes what's common, not what's ideal.
That's why two people can both get a "normal" result on the same test with very different implications. A ferritin of 15 ng/mL and a ferritin of 150 ng/mL might both sit inside one lab's stated reference range, but the person at 15 is far closer to iron-deficiency symptoms than the person at 150. The label "normal" hides that gap.
It also explains why the disagreement persists: conventional medicine's reference range is built to answer one question — is this result outside the range associated with a diagnosable disease? Functional-medicine and longevity practitioners are asking a different question — is this result in the part of the range associated with feeling and functioning well? Both questions are legitimate. They just aren't the same question, and a single number can answer one while leaving the other open.
Functional-medicine practitioners and platforms propose narrower target ranges. These numbers are specific to the sources cited — not a FixFirst recommendation.
| Biomarker | Standard reference range | "Optimal" range proposed | Source |
|---|---|---|---|
| Fasting glucose | 70–99 mg/dLGuideline borderline: 100–125 (ADA) → | 75–86 mg/dL | OptimalDX |
| TSH | 0.45–4.5 mIU/LWhen a guideline calls it borderline → | 1–2 mIU/L | OptimalDX |
| Vitamin D | 30–100 ng/mLGuideline borderline: 20–29 → | 50–90 ng/mL | OptimalDX |
| Magnesium | 1.5–2.6 mg/dL | >2.0 mg/dL | OptimalDX |
| Ferritin | Varies by lab and sexGuideline floor: 30 (NICE) → | >100 ng/mL | OptimalDX |
| hs-CRP | <3.0 mg/L (low risk)Guideline borderline: 1.0–3.0 → | <1.0 mg/L | KC Primary Care biomarker table |
| ApoB | Many labs print their own reference range; the 2026 ACC/AHA guideline sets risk-dependent goals and lists 120 mg/dL or higher as a risk-enhancing factorLongevity targets: under 60–80 → | <90 mg/dL (primary prevention, lower risk, triglycerides 150–499 mg/dL) · <70 mg/dL (higher risk) · <55 mg/dL (clinical ASCVD at very high risk) | 2026 ACC/AHA Dyslipidemia Guideline Figure 1; risk enhancer at 120 mg/dL or higher |
Notice that none of these "optimal" figures come with a citation to a clinical trial showing better outcomes at the narrower band. That's the honest caveat: some track mainstream guidance reasonably well (a TSH near 1–2 is a target many endocrinologists would agree is preferable to sitting at 4.5), while others are narrower than anything a published guideline supports, and vary from one functional-medicine source to the next.
ApoB is the one row in this table that isn't a functional-medicine opinion at all — it's mainstream cardiology, and it just moved. The 2026 ACC/AHA multisociety dyslipidemia guideline sets risk-dependent ApoB goals in its Figure 1: under 90 mg/dL for primary prevention at lower risk when triglycerides are 150–499 mg/dL, under 70 mg/dL at higher risk (same triglyceride range for primary prevention), and under 55 mg/dL for clinical ASCVD at very high risk, and it lists 120 mg/dL or higher as a risk-enhancing factor. It's a useful case study for the whole "normal vs. optimal" debate: the target isn't fixed, it depends on your risk group and is set with a clinician, and the lower figures longevity physicians quote are their own targets, not guideline goals.
Named longevity physicians and researchers publish their own versions of this same table, ApoB included. The Longevity blood markers section covers what Peter Attia, Andrew Huberman, and others have cited publicly, each target attributed to the person and the source rather than treated as a FixFirst claim.
Not every "optimal" claim carries the same weight. Here's how to tell the difference.
A TSH in the 1–2 mIU/L range being preferable to one near the top of the reference range (4.5) reflects fairly broad endocrine opinion, even though it isn't a universal diagnostic cutoff. ApoB is different: the 2026 ACC/AHA guideline itself publishes risk-dependent ApoB goals, though the lower figures people quote are personal targets, not guideline goals.
Ferritin above 100 ng/mL as a symptom-free target is a reasonable clinical observation in iron-deficiency research, but there's no single agreed number, and it can shift with inflammation.
Narrow bands for glucose or magnesium that tighten a wide clinical range by 60–80% aren't supported by outcome studies — they're a functional-medicine practice pattern, not a guideline.
The risk in treating every "optimal" number as a target is that chasing it can lead to unsupervised supplementation aimed at a band that was never clinically validated — for example, iron or vitamin D supplementation pushed toward the top of an "optimal" range without a documented deficiency, which carries its own downside. Use these ranges as a prompt for a conversation with your doctor, not a self-treatment target.
FixFirst doesn't invent its own "optimal" band for your results — we won't hand you a number nobody can defend. What it does instead is rank every marker on your report by clinical priority, using established sex- and age-adjusted thresholds, so you can see which "normal" results are borderline and worth watching, and which abnormal ones actually matter most right now. That's a narrower, more defensible promise than "optimal" — but it's the part of this problem that's actually solvable today.
Upload your report and get a ranked, evidence-based read on every marker — including the borderline values inside the reference range that most labs don't flag. 45 seconds, free, no account.
Analyse My Report Free